Antihypertensive medications and COVID-19 diagnosis and mortality: Population-based case-control analysis in the United Kingdom.

Rezel-Potts, Emma; Douiri, Abdel; Chowienczyk, Phil J; Gulliford, Martin C

Rezel-Potts, Emma; Douiri, Abdel; Chowienczyk, Phil J; Gulliford, Martin C.

Afiliação

Rezel-Potts E; King's College London, School of Population Health and Environmental Sciences, London, UK.
Douiri A; National Institute for Health Research Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.
Chowienczyk PJ; King's College London, School of Population Health and Environmental Sciences, London, UK.
Gulliford MC; National Institute for Health Research Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.

Br J Clin Pharmacol ; 87(12): 4598-4607, 2021 12.

Article em En | MEDLINE | ID: mdl-33908074

Assuntos

COVID-19; Hipertensão; Antagonistas de Receptores de Angiotensina/uso terapêutico; Inibidores da Enzima Conversora de Angiotensina/uso terapêutico; Anti-Hipertensivos/uso terapêutico; Teste para COVID-19; Estudos de Casos e Controles; Humanos; Hipertensão/diagnóstico; Hipertensão/tratamento farmacológico; Hipertensão/epidemiologia; SARS-CoV-2

Palavras-chave

COVID-19; SARS-CoV-2; angiotensin converting enzyme inhibitors; angiotensin receptor blockers; antihypertensive treatment; clinical practice research datalink; renin-angiotensin-aldosterone system inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Hipertensão Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google